Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Parexel Expands Regulatory Capability with Liquent Purchase

On the 27th December 2012, Parexel announced they had completed the purchase of Regulatory Submissions experts Liquent for $72m from Marlin Equity Partners. Liquent is a global provider of Regulatory Information Management solutions to more than 200 biopharmaceutical and life science companies across the globe. Liquent currently have offices based in Pennsylvania (Headquaters), UK, Germany and India. Liquent currently employ nearly 300 staff.

The purchase gives Parexel access to Liquents flagship software InSight. The software will give Parexel clients access to a comprehensive regulatory-submission planning, viewing, tracking, publishing and registrations management throughout the entire lifecycle of any given medical entity. Liquent is expected to contribute very little revenue to Parexel initially with Q2 2013 forecast to be around $17m and $23m of service revenue during the second half of the year.

The purchase of Liquent will not only expand Parexels regulatory offering but enhance the capabilities of Parexel’s Perspective Informatics Unit and its consulting and medical communications service.

To read the full press release please click here

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap